Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.07.007Source: DataRank Database

Proteogenomic insights suggest druggable pathways in endometrial carcinoma is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 1.2. It has been cited 54 times, with 38 citing works in its 1-hop citation network.

N/A

1.2DataRank · unranked

Scored on demand from live citation data

Open Access54 citations · 38 citing works in its network

Download PDF

Cite:

Linked data & code

dbgap hpa nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)Impact (FWCI 5.02)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 51%Citation Network 49%

Base Score Contribution

0.601

From this paper's citation signal

Citation Network Contribution

0.585

From 26 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 38 citers.

BDI-Kit: An AI-powered toolkit for biomedical data harmonization
Patterns20261 citations10 referencesContributes 0.069
Clinical-proteomic classification and precision treatment strategy of chordoma
Cell Reports Medicine20249 citations39 referencesContributes 0.059
AI-Augmented Advances in the Diagnostic Approaches to Endometrial Cancer
Cancers20255 citations32 referencesContributes 0.056
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Nature Communications202436 citations76 referencesContributes 0.048
Endometrial Carcinoma: A Comprehensive Analysis of Clinical Parameters, Treatment Modalities, and Prognostic Outcomes at a Tertiary Oncology Center in the UAE
Cureus20234 citations36 referencesContributes 0.045

Authors (100)

Lizabeth Katsnelson ORCID,Marina A. Gritsenko,Yingwei Hu ORCID,Boris Reva ORCID,Runyu Hong ORCID

Live enrichment

PubMed:37567170 PMC:PMC10631452 OpenAlex:https://openalex.org/W4385738280

U.S. Department of Defense

Grant: DOD BC220523

National Institutes of Health

Grant: U24CA271114

National Institutes of Health

Grant: U24CA210967

National Institutes of Health

Grant: U24CA210954

National Institutes of Health

Grant: U01CA214125

National Institutes of Health

Grant: U24CA210985

National Institutes of Health

Grant: U24CA210979

National Institutes of Health

Grant: U01CA214114

National Institutes of Health

Grant: U24CA271076

National Institutes of Health

Grant: U24CA271012

National Institutes of Health

Grant: U24CA210986

National Institutes of Health

Grant: 21X164Q

National Institutes of Health

Grant: U01CA214116

National Institutes of Health

Grant: S21-167

National Institutes of Health

Grant: U24CA210993

National Institutes of Health

Grant: U24CA210955

U.S. Department of Energy

Grant: DE-AC05-76RL01830

National Cancer Institute

Grant: U24CA210972

National Cancer Institute

Grant: RR160027

National Cancer Institute

Grant: T32CA203690

NIGMS NIH HHS

Grant: T32 GM115313

NIGMS NIH HHS

Grant: T32 GM136542

NCI NIH HHS

Grant: U24 CA271075

NCI NIH HHS

Grant: P30 CA046592

NIEHS NIH HHS

Grant: P30 ES017885

Cancer Prevention and Research Institute of Texas

Pacific Northwest National Laboratory

FWCI

5.02

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S1535610823002477-fx1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1535610823002477-fx1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1535610823002477?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823002477?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2023.07.007

Fields of Study

PI3K/AKT/mTOR signaling in cancerCancer Genomics and DiagnosticsCancer-related Molecular PathwaysFemaleHumansProto-Oncogene Proteins c-aktProspective StudiesProteogenomicsEndometrial Neoplasmsbeta CateninMetformin

MeSH Terms

ProteogenomicsFemaleHumansMetforminProspective StudiesEndometrial NeoplasmsProto-Oncogene Proteins c-aktbeta Catenin

Keywords

DruggabilityCancer researchWnt signaling pathwayBiologyProtein kinase BPhosphorylationCarcinomaBioinformaticsImmunotherapyMedicineOncologyInternal medicineSignal transductionCancerGeneGeneticsMetforminEndometrial CancerProteogenomicsCtnnb1Pik3r1Deep LearningCptacTarget Assays

Sustainable Development Goals

SDG 0: Good health and well-being